BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12107376)

  • 1. Biochemical mechanisms of cellular catabolism.
    Tisdale MJ
    Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):401-5. PubMed ID: 12107376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
    Whitehouse AS; Tisdale MJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
    Whitehouse AS; Khal J; Tisdale MJ
    Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between skeletal muscle proteolysis and ubiquitin-proteasome proteolytic pathway in burned rats.
    Chai J; Wu Y; Sheng Z
    Burns; 2002 Sep; 28(6):527-33. PubMed ID: 12220909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.
    Gomes-Marcondes MC; Smith HJ; Cooper JC; Tisdale MJ
    Br J Cancer; 2002 May; 86(10):1628-33. PubMed ID: 12085214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms controlling protein degradation in catabolic states.
    Ding X; Price SR; Bailey JL; Mitch WE
    Miner Electrolyte Metab; 1997; 23(3-6):194-7. PubMed ID: 9387115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of skeletal muscle in cancer: biochemical mechanisms.
    Tisdale MJ
    Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
    Jagoe RT; Goldberg AL
    Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):183-90. PubMed ID: 11517350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms regulating protein turnover in muscle.
    Price SR; Du JD; Bailey JL; Mitch WE
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S112-4. PubMed ID: 11158874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.
    Kee AJ; Combaret L; Tilignac T; Souweine B; Aurousseau E; Dalle M; Taillandier D; Attaix D
    J Physiol; 2003 Feb; 546(Pt 3):765-76. PubMed ID: 12563002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid.
    Smith HJ; Tisdale MJ
    Apoptosis; 2003 Mar; 8(2):161-9. PubMed ID: 12766476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
    Khal J; Tisdale MJ
    Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
    Hasselgren PO; Fischer JE
    Ann Surg; 1997 Mar; 225(3):307-16. PubMed ID: 9060588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats.
    Combaret L; Rallière C; Taillandier D; Tanaka K; Attaix D
    Mol Biol Rep; 1999 Apr; 26(1-2):95-101. PubMed ID: 10363654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
    Hasselgren PO
    Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.